Mirae Asset Global Investments
ICPT

Mirae Asset Global Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Mirae Asset Global Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,690
Closed -$680K – 2641
2023
Q3 		$680K Buy
36,690
+10,787
+42% +$122K ﹤0.01% 1737
2023
Q2 		$288K Buy
25,903
+4,150
+19% +$57.8K ﹤0.01% 2198
2023
Q1 		$292K Buy
21,753
+9,844
+83% +$170K ﹤0.01% 2181
2022
Q4 		$147K Buy
11,909
+304
+3% +$4.3K ﹤0.01% 2373
2022
Q3 		$162K Buy
+11,605
New +$187K ﹤0.01% 2400

Mirae Asset Global Investments's ICPT Position: Q4 2023 in Review

Mirae Asset Global Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 36,690 shares — an estimated $680K sold.

Mirae Asset Global Investments first reported a position in ICPT in Q3 2022 and held it in 5 quarters. The position peaked at $680K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Mirae Asset Global Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 36,690 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $680K.
  • Mirae Asset Global Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2022 and held it in 5 quarters.
  • Mirae Asset Global Investments's Intercept Pharmaceuticals, Inc. position peaked at $680K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Mirae Asset Global Investments's 13F filing for Q4 2023, filed 24 Jan 2024.